Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid

Parasite Immunology

Volumn 21, Issue 11, 1999, Pages 573-581

  Vincent, Arokia A ^a   Fanning, Sarah ^a   Caira, Francesco C ^a   Williamson, Kim C ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Malaria; Pfs230; Plasmodium falciparum; Transmission blocking; Vaccine

Indexed keywords

MALARIA VACCINE; MEMBRANE ANTIGEN; RECOMBINANT PROTEIN; TETANUS TOXOID;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG CONJUGATION; ESCHERICHIA COLI; FEMALE; GENE LOCATION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPRECIPITATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALARIA; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; SACCHAROMYCES CEREVISIAE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MALARIA VACCINES; MICE; PLASMODIUM FALCIPARUM; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; TETANUS TOXOID; TRANSFORMATION, BACTERIAL; VACCINES, CONJUGATE;

ANIMALIA; ESCHERICHIA COLI; PLASMODIUM FALCIPARUM; PROTOZOA; SACCHAROMYCES CEREVISIAE;

EID: 0032719678     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.1999.00255.x     Document Type: Article

References (36)

1. Amante F.H., Crewther P.E., Anders R.F. et al. (1997) A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: Implications for malaria vaccine design. Journal of Immunology 159, 5535-5544
2. Ballou W.R., Hoffman S.L., Sherwood J.A. et al. (1987) Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1, 1277-1281
3. Barnes D.A., Wollish W., Nelson R.G. et al. (1995) Plasmodium falciparum: D260, an intraerythrocytic parasite protein, is a member of the glutamic acid dipeptide-repeat family of proteins. Experimental Parasitology 81, 79-89
4. Borre M.B., Dziegiel M., Hogh B, et al. (1991) Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Molecular Biochemistry and Parasitology 49, 119-131
5. Carter R., Graves P.M., Quakyi I.A. et al. (1989) Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies. Journal of Experimental Medicine 169, 135-147
6. Daly T.M. & Long C.A. (1993) A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein I induces a protective immune response in mice. Infection and Immunity 61, 2462-2467
7. Egan A., Waterfall M., Pinder M. et al. (1997) Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein I: Evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds. Infection and Immunity 65, 3024-3031
8. Etlinger H.M., Gillessen D., Lahm H.W. et al. (1990) Use of prior vaccinations for the development of new vaccines. Science 249, 423-425
9. Garrity R.R., Rimmelzwaan G., Minassian A. el al. (1997) Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. Journal of Immunology 159, 279-289
10. Good M.F., Miller L.H., Kumar S. et al. (1988) Limited immunological recognition of critical malaria vaccine candidate antigens. Science 242, 574-577
11. Graves P.M., Carter R., Burkot T.R. et al. (1988) Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunology 10, 209-218
12. Healer J., McGuinness D, Hopcroft P. et al. (1997) Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230. Infection and Immunity 65, 3017-3023
13. Herrington D.A., Clyde D.F., Losonsky G. et al. (1987) Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 328, 257-259
14. Hoffman S.L., Edelman R., Bryan J.P. et al. (1994) Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant. American Journal of Tropical Medicine and Hygiene 51, 603-612
15. Hogh B., Petersen E., Dziegiel M. et al. (1992) Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: Evidence for protection of dividuals living in a holoendemic area of Liberia. American Journal of Tropical Medicine and Hygiene 46, 307-313
16. Hui G.S., Gosnell W.L., Case S.E. et al. (1994) Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSPI), YMSP1 (19) expressed in S. cerevisiae. Journal of Immunology 153, 2544-2553
17. Ifediba T. & Vanderberg J.P. (1981) Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature 294, 364-366
18. Kaslow D.C. (1993) Transmission-blocking immunity against malaria and other vector-borne diseases. Current Opinion in Immunology 5, 557-565
19. Kumar A., Arora R., Kaur P. et al. (1992) 'Universal' T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. Journal of Immunology 148, 1499-1505
20. Kumar N. & Carter R. (1984) Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum. Molecular Biochemistry and Parasitology 13, 333-342
21. Mattei D., Berzins K., Wahlgren M. et al. (1989) Cross-reactive antigenic determinants present on different Plasmodium falciparum blood-stage antigens [published erratum appears in Parasite Immunology (1989) 11, 299]. Parasite Immunology 11, 15-29
22. Panina-Bordignon P., Tan A., Termijtelen A. et al. (1989) Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells. European Journal of Immunology 19, 2237-2242
23. Patera A.C., Graham C.M., Thomas DB. et al. (1995) Immunodominance with progenitor B cell diversity in the neutralizing antibody repertoire to influenza infection. European Journal of Immunology 25, 1803-1809
24. Quakyi I.A., Carter R., Rener J. et al. (1987) The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. Journal of Immunology 139, 4213-4217
25. Read D., Lensen A.H., Begarnie S. et al. (1994) Transmission-blocking antibodies against multiple, non-variam target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing. Parasite Immunology 16, 511-519
26. Riley E.M., Bennett S., Jepson A. et al. (1994) Human antibody responses to Pfs 230, a sexual stage-specific surface antigen of Plasmodium falciparum: Non-responsiveness is a stable phenotype but does not appear to be genetically regulated. Parasite Immunology 16, 55-62
27. Roeffen W., Beckers P.J., Teelen K. et al. (1995) Plasmodium falciparum: A comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs. Experimental Parasitology 80, 15-26
28. Schneerson R., Robbins J.B., Parke J.C. Jr et al. (1986) Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infection and Immunity 52, 519-528
29. Taylor R.R., Egan A., McGuinness D. et al. (1996) Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. International Immunology 8, 905-915
30. Tian J.H., Miller L.H., Kaslow D.C. et al. (1996) Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. Journal of Immunology 157, 1176-1183
31. Vermeulen A.N., van Deursen J., Brakenhoff R.H. et al. (1986) Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures. Molecular Biochemistry and Parasitology 20, 155-163
32. Wang R., Charoenvit Y., Corradin G. et al. (1995) Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine [published erratum appears in Journal of Immunology (1995) 155, 1637]. Journal of Immunology 154, 2784-2793
33. + T cell- and IFN-gamma-dependent elimination affected hepatocytes. Journal of Immunology 157, 4061-4067
34. Williamson K.C., Criscio M.D. & Kaslow D.C. (1993) Cloning and expression of the gene for Plasmadium falciparum transmission-blocking target antigen, Pfs230. Molecular Biochemistry and Parasitology 58, 355-358
35. Williamson K.C., Fujioka H., Aikawa M. et al. (1996) Stage-specitic processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate. Molecular Biochemistry and Parasitology 78, 161-169
36. Williamson K.C., Keister D.B., Muratova O. et al. (1995) Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Molecular Biochemistry and Parasitology 75, 33-42